Immunotherapeutic approaches for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment, recurrence is common. Sorafenib and regorafenib are the only therapeutic agents that have been demonstrated to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Vito, Gnoni, Antonio, Gardini, Andrea Casadei, Pisconti, Salvatore, Licchetta, Antonella, Scartozzi, Mario, Memeo, Riccardo, Palmieri, Vincenzo Ostilio, Aprile, Giuseppe, Santini, Daniele, Nardulli, Patrizia, Silvestris, Nicola, Brunetti, Oronzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464921/
https://www.ncbi.nlm.nih.gov/pubmed/28420805
http://dx.doi.org/10.18632/oncotarget.15406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464921/
https://www.ncbi.nlm.nih.gov/pubmed/28420805
http://dx.doi.org/10.18632/oncotarget.15406

Ejemplares similares